Abstract
Modern strategies to deliver drugs efficiently via less toxic non-aqueous carriers like deep eutectic solvents (DES) has grown tremendously. Herein, we develop several synthetic and natural DES to improve solubility of poorly soluble drug, docetaxel (DTX). Menthol:thymol-based natural DES showed 1500-folds higher solubility for DTX than that in water. FTIR-spectroscopy confirmed reduced crystallinity and stable encapsulation of DTX in DES through formation of hydrogen-bond. DTX-DES was developed further into self-emulsified formulation that upon dilution formed nanostructured globules (< 200 nm) and released 20-folds higher DTX than pure drug thereby highlighting the potential of DES for designing formulations of poorly soluble drugs.
Graphical Abstract
Similar content being viewed by others
Data availability
The data can be made available on reasonable request.
References
S. Kalepu, M. Mohanvarma, P. Veerabhadhraswamy, Oral lipid-based drug delivery systems–An overview. Acta Pharm. Sin. B 3(6), 361–372 (2013)
R. Kesharwani, P. Jaiswal, D.K. Patel, P.K. Yadav, Lipid-based drug delivery system (LBDDS): An emerging paradigm to enhance oral bioavailability of poorly soluble drugs. Biomed. Mater. Devices (2022). https://doi.org/10.1007/s44174-022-00041-0
C.W. Pouton, Lipid formulations for oral administration of drugs: Non-emulsifying, self-emulsifying and ‘self-microemulsifying’drug delivery systems. Eur. J. pharm. Sci. 11, S93–S98 (2000)
R. Kadian, N. Arun, A comprehensive insight on recent advancements in self-emulsifying drug delivery systems. Curr. Drug Deliv. 20(8), 1095–1114 (2023)
J. Wang, M. Li, L. Duan, Y. Lin, X. Cui, Y. Yang, C. Wang, Deep eutectic systems as novel vehicles for assisting drug transdermal delivery. Pharmaceutics 14(11), 2265 (2022)
J. Kim, Y. Shi, C.J. Kwon, Y. Gao, S. Mitragotri, A deep eutectic solvent-based approach to intravenous formulation. Adv. Healthc. Mater. 10(18), 2100585 (2021)
S. Emami, S. Ali, Deep eutectic solvents for pharmaceutical formulation and drug delivery applications. Pharm. Dev. Technol. 25(7), 779–796 (2020)
D.Z. Troter, Z.B. Todorović, D.R. Đokić-Stojanović, B.S. Dorđević, V.M. Todorović, S.S. Konstantinović, V.B. Veljković, The physicochemical and thermodynamic properties of the choline chloride-based deep eutectic solvents. J. Serb. Chem. Soc. 82(9), 1039–1052 (2017)
M.M. Abdelquader, S. Li, G.P. Andrews, D.S. Jones, Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications. Eur. J. Pharm. Biopharm. 186, 85–104 (2023)
M. Hayyan, Versatile applications of deep eutectic solvents in drug discovery and drug delivery systems: Perspectives and opportunities. Asian J. Pharm. Sci. 18(2), 1–3 (2023)
S.N. Pedro, C.S. Freire, A.J. Silvestre, M.G. Freire, Deep eutectic solvents and pharmaceuticals. Encyclopedia 1(3), 942–963 (2021)
L. Feng, R.J. Mumper, A critical review of lipid-based nanoparticles for taxane delivery. Cancer Lett. 334(2), 157–175 (2013)
S.N. Murthy, H.N. Shivakumar, Topical and transdermal drug delivery, In personal care & cosmetic technology, handbook of non-invasive drug delivery systems. ed. by V.S. Kulkarni (William Andrew Publishing, Norwich, 2010), pp.1–36
F. Bergua, M. Castro, C. Lafuente, M. Artal, Thymol+ l-menthol eutectic mixtures: Thermophysical properties and possible applications as decontaminants. J. Mol. Liq. 368, 120789 (2022)
Y. Kaplun-Frischoff, E. Touitou, Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids. J. Pharm. Sci. 86(12), 1394–1399 (1997)
S. Mohammadi-Samani, G. Yousefi, F. Mohammadi, F. Ahmadi, Meloxicam transdermal delivery: Effect of eutectic point on the rate and extent of skin permeation. Iran. J. Basic Med. Sci. 17(2), 112 (2014)
P.W. Stott, C.W. Adrian, W.B. Brian, Transdermal delivery from eutectic systems: Enhanced permeation of a model drug, ibuprofen. J. Control Rel. 50(1–3), 297–308 (1998)
J.B. Cannon, LIPIDS-strategies to formulate lipid-based drug delivery systems. Am. Pharm. Rev. 14(4), 84 (2011)
S. Thambiraj, R. Vijayalakshmi, D. Ravi Shankaran, An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer. Sci. Rep. 11(1), 2808 (2021)
Acknowledgments
The authors would like to acknowledge the support of Massachusetts Life Sciences Center (MLSC) for UPLC/MS equipment grant.
Funding
This work was funded by Massachusetts Life Sciences Center (MLSC), Boston, MA.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception. BS contributed to study design. BS and RO contributed to experimentation and analysis. BS contributed to writing original draft of the manuscript. SS contributed to supervision, review, and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shah, B.M., Owyeung, R.E. & Sonkusale, S. Development of deep eutectic solvent systems and their formulation: Assessment of solubilization potential on poorly water-soluble drugs. MRS Communications (2024). https://doi.org/10.1557/s43579-024-00552-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1557/s43579-024-00552-5